Laurie Keating, EVP, Chief Legal Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 94,500 shares at $161.32 ($15.2M) on 2020-07-13, disclosed to the SEC on 2020-07-14.
Open-market sale of $15.2M ALNY by EVP, Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $157.16 | 4,482 | $704K | 4.6% |
| 2 | $157.16 | 4,482 | $704K | 4.6% |
| 3 | $158.27 | 2,323 | $368K | 2.4% |
| 4 | $158.27 | 2,323 | $368K | 2.4% |
| 5 | $159.22 | 1,061 | $169K | 1.1% |
| 6 | $159.22 | 1,061 |
| $169K |
| 1.1% |
| 7 | $160.52 | 14,236 | $2.3M | 15.1% |
| 8 | $160.52 | 14,236 | $2.3M | 15.1% |
| 9 | $161.32 | 15,618 | $2.5M | 16.6% |
| 10 | $161.32 | 15,618 | $2.5M | 16.6% |
| 11 | $162.24 | 9,530 | $1.5M | 10.2% |
| 12 | $162.24 | 9,530 | $1.5M | 10.2% |
| Total | $160.67 avg | 94,500 | $15.2M | 100% |
| Filing → |
| ALNY | SELL | 2021-08-09 | $1.9M | — | Filing → |
| IMRX | BUY | 2021-08-04 | $105K | — | Filing → |
| ALNY | SELL | 2021-07-14 | $1.2M | — | Filing → |